PXS-25

N/A

Report date: 2022/01/22 15:45:34

NME

Base Information

Drug NamePXS-25

Drug Alias NamePXS-25

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTransforming growth factor beta 1 inhibitors

TargetsTransforming growth factor beta 1

Therapy Area/IndicationsPulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSyntara Ltd

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSyntara Ltd

Active IndicationsN/A

Inactive IndicationsPulmonary Fibrosis

ATC CodeN/A